Alphabet in July, after serving as CFO at pharmaceutical company Eli Lilly for three years. At a tech conference earlier this ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other stocks. Some of the major U.S. indexes began recovering on Wednesday, following the ...

Lucas Montarce, who was appointed as Eli Lilly's top finance chief in September, received $2.9 million in total compensation in 2024. Montarce succeeded Anat Ashkenazi, who left the company ...

(RTTNews) - Eli Lilly and Co. (LLY) announced that its Ebglyss monotherapy monthly injection demonstrated sustained and deep responses in patients with moderate-to-severe atopic dermatitis over ...

Earlier this week, Eli Lilly partnered up with telehealth providers LifeMD and Teladoc Health to offer its lower cost, single-vial Zepbound (tirzepatide) to patients in the virtual care companies ...

Plenty of health care names are under accumulation right now. But there’s a powerful fundamental story happening with Eli Lilly. Also, EPS is estimated to ramp higher this year by +27.4%.

In a fireside chat during the Morgan Stanley Technology, Media and Telecom Conference on Tuesday, Ashkenazi discussed Waymo, an Alphabet company that develops self-driving technol ...

Good morning. Anat Ashkenazi, CFO of Alphabet, Google's parent company, is investing big in AI infrastructure, but supporting other bets, like autonomous vehicle development, is also on her agenda.

Nick Blackmer is a librarian, fact-checker, and researcher with more than 20 years of experience in consumer-facing health and wellness content. Eli Lilly has reduced the prices of certain ...

Whales with a lot of money to spend have taken a noticeably bullish stance on Eli Lilly. Looking at options history for Eli Lilly (NYSE:LLY) we detected 25 trades. If we consider the specifics of ...

Now Novo Nordisk and Indianapolis-based rival Eli Lilly and Co. are seeking to capture the large market of consumers who purchased compounded weight-loss drugs to get lower prices. David Kim ...